Sireesha Dasari, MD
Family Medicine · Parkersburg, WVNPI 1386855484
Payments from drug & device makers
Across 130 payments — averaging $16.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$581
- AbbVie$439
- AstraZeneca$185
- Lilly USA, LLC$128
- Corcept Therapeutics$119
- GSK$94
- plus $582 from 15 others
What the payments were for
- Food & beverage$2,127100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 40 | $581 |
| AbbVie(2 entities) | 25 | $439 |
| AstraZeneca | 12 | $185 |
| Lilly USA, LLC | 8 | $128 |
| Corcept Therapeutics | 6 | $119 |
| GSK | 6 | $94 |
| Amgen(2 entities) | 4 | $74 |
| Exact Sciences | 4 | $72 |
| Pfizer | 4 | $64 |
| Viiv Healthcare Company | 2 | $59 |
| Abbott | 3 | $46 |
| Novartis | 3 | $45 |
| Eisai Inc. | 3 | $40 |
| Boehringer Ingelheim | 2 | $33 |
| Amarin Pharma, Inc. | 2 | $32 |
| Melinta Therapeutics, LLC | 1 | $22 |
| Bayer | 1 | $21 |
| Valeritas, Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Hologic Sales And Service, LLC | 1 | $17 |
How this compares
$2,127 in reported general payments places this provider in the 80th percentile of 843 family medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 175 | $212,525 |
| JardianceEmpagliflozin | 110 | $140,900 |
| LinzessLinaclotide | 142 | $91,935 |
| EliquisApixaban | 102 | $89,508 |
| TrulicityDulaglutide | 68 | $83,173 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 57 | $67,957 |
| VascepaIcosapent Ethyl | 93 | $49,213 |
| JanuviaSitagliptin Phosphate | 36 | $36,432 |
| XareltoRivaroxaban | 24 | $28,446 |
| Breo ElliptaFluticasone/Vilanterol | 47 | $27,317 |
| RybelsusSemaglutide | 24 | $26,295 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $22,733 |
| MounjaroTirzepatide | 23 | $21,657 |
| VraylarCariprazine Hcl | 14 | $20,715 |
| UbrelvyUbrogepant | 19 | $17,539 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $581 | $238,820199 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta | $33 | $171,055145 claims |
| AbbVieLinzess, Vraylar, Ubrelvy | $439 | $130,188175 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Shingrix, Arexvy | $94 | $110,654183 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $128 | $104,83091 claims |
| PfizerEliquis, Nurtec Odt | $64 | $104,402114 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $185 | $53,73459 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 843 family medicine providers in West Virginia.
Other family medicine in Parkersburg
- James SpychalskiParkersburg$16K
- Wilbur SineMorgantown$179K
- Dorian WilliamsMorgantown$169K
- Julie DetempleSouth Charleston$129K
- Clemente DiazRichwood$127K
- John CornellHuntington$94K
- Mark CucuzzellaHarpers Ferry$59K
- Courtney PilkertonMorgantown$45K
- Isha WoofterClarksburg$27K
- Dominick WoofterClarksburg$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.